Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

A HUMANIZED MOUSE MODEL FOR EVALUATION OF AUTOLOGOUS HIV-SPECIFIC T-CELL THERAPIES

By Enthusiast Inc MDMarch 7, 2019

…or HIV+ donor leukapheresis samples. Autologous HSTs were generated by stimulating T-cells with pools of overlapping Clade B consensus peptides or peptides representing only conserved viral epitopes. Four to six…

THE HEALTH IMPACT OF SEXUAL VIOLENCE AMONG WOMEN IN A PLATINUM MINING BELT

By Enthusiast Inc MDFebruary 16, 2017

…IPV was 45% – >82000 women. Lifetime prevalence of NP-rape was 18% – >28000 women and girls. Very few sought care – 5% told a health care professional about their…

HIV Myeloid-Derived Suppressor Cells Inhibit the Protective Response to Cytomegalovirus

By Enthusiast Inc MDSeptember 29, 2014

…on CMV specific effector cells. Methodology: Peripheral blood mononuclear cells (PBMCs) obtained from HIV seronegative, CMV seropositive healthy donors were cultured in presence of heat inactive HIVBaL. After 5 days,…

972 – Effect of Tuberculosis Preventive Therapy on Mtb-Specific T-Cell Profile in the A5279/BRIEF TB Trial

By Jimmy He PharmD, DScMarch 20, 2025

…pp65 peptide pool, Mtb ESAT-6/CFP-10 peptide pool, and whole cell Mtb lysate (WCTBL). Cells incubated in media alone served as a negative control. PBMCs were stained for markers of T…

964 – HIV Detection in Emergency Departments Through a Targeted Screening Protocol: The VIHGILA Project

By Jimmy He PharmD, DScMarch 31, 2026

…VIHGILA project, implemented in 25 hospitals in Catalonia (Spain), has aimed to proactively diagnose HIV infection across six clinical scenarios: suspected sexually transmitted infection (STI), chemsex, post-exposure prophylaxis (PEP) request,…

Vaccine Targeting Protease Cleavage Sites Protects Cynomolgus Monkeys Against SIV

By Enthusiast Inc MDFebruary 16, 2016

…enzyme that mediates the cleavage of Gag, Gag-Pol and Nef precursor polyproteins. This process is a highly specific, temporally regulated and essential for the production of infectious viral particles. A…

EXPRESSION OF CD32 IN HIV-RESERVOIR CELLS CONFERS RESISTANCE TO NATURAL KILLER CELLS

By Jimmy He PharmD, DScApril 22, 2021

…appropriate. CD4+ T cells expressing CD32 were highly resistant to ADCC after peptide-loading (ANOVA p=0.0001) (Figure 1), and ex-vivo infection (median % 19.6 vs. 35.8 for TCD32+ and TCD32-, p…

T-CELL RESPONSE QUALITY TO ACUTE SARS-CoV-2 INFECTION, IMMUNE MEMORY, AND HCoV

By Jimmy He PharmD, DScApril 4, 2022

…with Spike (S) and Nucleocapside (N) SARS-COV-2 peptide pools. Likewise, an optimized peptide pool of HCoV S protein was used in HD. T-cell polyfunctionality by intracellular cytokine staining (IFN-?, IL-2,…

Strong IFN-g Responses and Limited HIV Reservoirs in Adolescent Virologic Controllers

By Enthusiast Inc MDFebruary 16, 2016

…cell-mediated immune responses (CMI); and HLA typing. CMI were assessed using pooled clade-matched HIV-1 Gag peptide panels in matrix format and IFN-g ELISpot and expressed as spot-forming units (SFU) per…

SARS-CoV-2 Mild Infection as Risk Factor for Herpes Human Viruses Reactivation

By Jimmy He PharmD, DScMarch 6, 2024

…production after whole blood stimulation with SARS-CoV-2-spike peptides, HHV peptides designed to elicit CD4/CD8 response for Varicella Zoster Virus (VZV), Cytomegalovirus (CMV), HHV1/2, Epstein-Barr virus (EBV), and IL-2, IL-6, IL-8,…

←1
23456789101112131415161718192021222324252627282930313233
…3435363738…
3940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top